The ROE as of September 2024 (TTM) for CTI BioPharma Corp. (CTIC) is 180.42%

According to CTI BioPharma Corp.’s latest financial reports and current stock price. The company's current ROE is 180.42%. This represents a change of 2.39% compared to the average of 176.21% of the last 4 quarters.

CTI BioPharma Corp. (CTIC) Historical ROE (quarterly & annually)

How has CTIC ROE performed in the past?

The mean historical ROE of CTI BioPharma Corp. over the last ten years is -366.99%. The current 180.42% ROE has changed -149.16% with respect to the historical average. Over the past ten years (40 quarters), CTIC's ROE was at its highest in in the June 2022 quarter at 429.73%. The ROE was at its lowest in in the June 2013 quarter at -1065.11%.

CTI BioPharma Corp. (CTIC) ROE by Quarter and Year

Discovering the peaks and valleys of CTI BioPharma Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CTI BioPharma Corp. (CTIC) Average ROE

How has CTIC ROE performed in the past?

The current ROE of CTI BioPharma Corp. (CTIC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

CTI BioPharma Corp. (CTIC) ROE vs. Peers

How is CTIC’s ROE compared to its peers?

CTI BioPharma Corp.’s ROE is less than Rigel Pharmaceuticals, Inc. (46.64%), greater than Fortress Biotech, Inc. (-226.63%), less than Reviva Pharmaceuticals Holdings, Inc. (7.96%), greater than Ocuphire Pharma, Inc. (-30.19%), greater than Protalix BioTherapeutics, Inc. (-45.15%), less than Seres Therapeutics, Inc. (313.56%), greater than Cidara Therapeutics, Inc. (-401.89%), less than ImmunityBio, Inc. (100.06%), less than Galera Therapeutics, Inc. (21.95%), less than Selecta Biosciences, Inc. (67.13%), less than Paratek Pharmaceuticals, Inc. (22.36%), greater than Corvus Pharmaceuticals, Inc. (-53.99%), greater than Immutep Limited (-42.11%), greater than Icosavax, Inc. (-41.24%), greater than Verastem, Inc. (-133.02%), greater than ImmunoGen, Inc. (-21.97%), greater than Intercept Pharmaceuticals, Inc. (-78.24%), greater than Elevation Oncology, Inc. (-57.97%), greater than Viking Therapeutics, Inc. (-15.05%), greater than TG Therapeutics, Inc. (-38.21%), less than X4 Pharmaceuticals, Inc. (32.93%), greater than PDS Biotechnology Corporation (-137.06%), greater than Madrigal Pharmaceuticals, Inc. (-95.61%),

Build a custom stock screener for CTI BioPharma Corp. (CTIC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CTI BioPharma Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CTI BioPharma Corp. (CTIC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CTI BioPharma Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.